Fund Holdings — Lion Point Capital, LP

Total Portfolio Value:
$52.30M
Total Bought:
$8.91M
Total Sold:
$68.49M
Net Transaction:
-$59.58M
Notable People:
Carl Didric Marcus Cederholm
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Marinus Pharmaceuticals Inc2,134,3372,119,136-15,201$23.20M$19.16M36.63%-$4.04M
Ardelyx Inc1,151,6671,046,667-105,000$7.14M$7.64M14.61%+$500.3K
Milestone Pharmaceuticals Inc.(MIST)1,650,2072,300,207+650,000$2.76M$4.12M7.87%+$1.36M
Kiniksa Pharmaceuticals LtdCL A130,691130,6910$2.29M$2.58M4.93%+$286.2K
Geron Corporation(GERN)0600,000+600,000$0$1.98M3.79%+$1.98M
Insmed Incorporated(INSM)70,33570,3350$2.18M$1.91M3.65%-$271.5K
Fennec Pharmaceuticals Inc.(FENC)110,000170,000+60,000$1.23M$1.89M3.61%+$656.2K
Burgerfi International Inc2,745,9382,745,9380$2.36M$1.59M3.03%-$775.5K
Syndax Pharmaceuticals, Inc.(SNDX)34,50065,000+30,500$745.5K$1.55M2.96%+$801.5K
Avadel Pharmaceuticals PlcADR80,00082,500+2,500$1.13M$1.39M2.66%+$263.8K
Bluebird Bio Inc531,256848,256+317,000$733.1K$1.09M2.08%+$352.6K
Neurocrine Biosciences, Inc.(NBIX)07,500+7,500$0$1.03M1.98%+$1.03M
Jasper Therapeutics, Inc.(JSPR)032,000+32,000$0$939.5K1.80%+$939.5K
Enphys Acquisition CorpCL A78,12578,1250$833.6K$845.3K1.62%+$11.7K
Mineralys Therapeutics, Inc.(MLYS)060,000+60,000$0$774.6K1.48%+$774.6K
Humacyte, Inc.(HUMA)235,000235,0000$667.4K$730.9K1.40%+$63.5K
REGENXBIO Inc.(RGNX)032,500+32,500$0$684.8K1.31%+$684.8K
Travere Therapeutics, Inc.NOTE 2 250 3 0(TVTX)000$670.7K$629.5K1.20%-$41.2K
Travere Therapeutics, Inc.(TVTX)78,00078,0000$701.2K$601.4K1.15%-$99.8K
Replimune Group, Inc.(REPL)42,50042,5000$358.3K$347.2K0.66%-$11.1K
Seres Therapeutics, Inc.(MCRB)340,761340,7610$477.1K$263.8K0.50%-$213.3K
Lumos Pharma Inc90,79490,7940$288.7K$256.0K0.49%-$32.7K
Battalion Oil Corporation(BATL)222,18219,926-202,256$2.14M$112.8K0.22%-$2.02M
Burgerfi International IncW EXP 12 16 2022,083,4382,083,4380$93.8K$81.3K0.16%-$12.5K
Spruce Biosciences Inc075,000+75,000$0$58.9K0.11%+$58.9K
Microsoft Corporation(MSFT)1001000$37.6K$42.1K0.08%+$4.5K
Alphabet Inc.CL C(GOOG)1001000$14.1K$15.2K0.03%+$1.1K
Semtech Corporation(SMTC)2,577,85514-2,577,841$56.48M$3850.00%-$56.48M
Whitehawk Therapeutics, Inc.(WHWK)82,4230-82,423$166.5K$0—-$166.5K
Aclaris Therapeutics, Inc.(ACRS)115,8980-115,898$121.7K$0—-$121.7K
Amylyx Pharmaceuticals, Inc.(AMLX)14,0000-14,000$206.1K$0—-$206.1K
Cymabay Therapeutics Inc82,4250-82,425$1.95M$0—-$1.95M
Harpoon Therapeutics Inc228,9000-228,900$2.60M$0—-$2.60M
Mirum Pharmaceuticals, Inc.(MIRM)13,5000-13,500$398.5K$0—-$398.5K
Page 1 of 1
Lion Point Capital, LP — 13F Holdings — Q1 2024 | TickerTrail